Principal Securities, Inc. Genfit S.A. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Genfit S.A. stock. As of the latest transaction made, Principal Securities, Inc. holds 24 shares of GNFT stock, worth $90. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$90% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GNFT
# of Institutions
8Shares Held
53KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY25.5KShares$96,7200.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il18.8KShares$71,1110.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P74.64KShares$17,5810.0% of portfolio
-
Ubs Group Ag4.08KShares$15,4660.0% of portfolio
-
Rhumbline Advisers Boston, MA5Shares$180.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $189M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...